Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.

AIDS research and human retroviruses - 1 Apr 2005

Jones Dana, Parkin Neil, Hudelson Sarah E, Guay Laura A, Musoke Philippa, Mmiro Francis, Jackson J Brooks, Eshleman Susan H

Abstract excerpt

The HIVNET 012 trial in Uganda demonstrated that a regimen of single-dose nevirapine (NVP) can prevent HIV-1 mother-to-child transmission. Previous studies show that HIV-1 with one or more NVP resistance (NVPR) mutations can be selected in many women as early as 7 days after single-dose NVP. We evaluated the genetic linkage of NVPR mutations in plasma from women in HIVNET 012 collected 7 days after single-dose...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Protease

Share to HIV Reverse Transcriptase

Share to Nevirapine

Share to Pregnancy Complications, Infectious

Share to Reverse Transcriptase Inhibitors

Share to Uganda

Source

Identifiers

PMID: 15943576
DOI: 10.1089/aid.2005.21.319

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.PMID 15943576Read ↗

Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.Semantic proximity Read ↗

Nevirapine resistance after single dose prophylaxis.Semantic proximity Read ↗

Distinct Patterns of Emergence and Fading of K103N and Y181C in Women With Subtype A vs. D After Single-Dose NevirapineSemantic proximity Read ↗

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).Semantic proximity Read ↗

Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).Semantic proximity Read ↗

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.Semantic proximity Read ↗

Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysis.Semantic proximity Read ↗

Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.Semantic proximity Read ↗

Emergence and Persistence of Minor Drug-Resistant HIV-1 Variants in Ugandan Women after Nevirapine Single-Dose ProphylaxisSemantic proximity Read ↗

Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.Semantic proximity Read ↗

Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration.Semantic proximity Read ↗

Greater Suppression of Nevirapine Resistance With 21- vs 7-Day Antiretroviral Regimens After Intrapartum Single-Dose Nevirapine for Prevention of Mother-to-Child Transmission of HIVSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.